Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS safety_alert · 2017-08-31Clinical Trial Update: Neuropsychiatric Adverse Effects in Patients With Chronic Hepatitis C Treated by Direct Acting Antiviral Drugs
A clinical trial update notes potential neuropsychiatric adverse effects in patients with chronic hepatitis C treated with direct-acting ant…
-
CLINICAL_TRIALS safety_alert · 2017-01-13Clinical Trial Update: Telaprevir Exposure and Severe Anemia in HCV Infected Patients Treated by Tri-therapy
Clinical trial update notes exposure to telaprevir associated with severe anemia in hepatitis C patients treated with triple therapy; the st…
-
EMA safety_alert · 2016-12-02PRAC warns of risk of hepatitis B re-activation with direct-acting antivirals for hepatitis C
The EMA’s Pharmacovigilance Risk Assessment Committee warns that hepatitis B re-activation can occur in patients with past or current hepati…
-
EMA safety_alert · 2015-04-24EMA recommends avoidance of certain hepatitis C medicines and amiodarone together
EMA recommends avoiding concurrent use of certain hepatitis C medicines with amiodarone due to potential risk of severe bradycardia or heart…